Interleukin-1 induces interleukin-6 production in peripheral blood monocytes

G Tosato1, K D Jones

  • 1Division of Biochemistry and Biophysics, Food and Drug Administration, Bethesda, MD.

Blood
|March 15, 1990
PubMed

Insights

Interleukin-1 beta (IL-1) effectively induces Interleukin-6 (IL-6) production in human monocytes, a previously unrecognized interaction. This finding clarifies the cytokine signaling pathways and biological activities of IL-1 and IL-6.

Area of Science:

  • Immunology
  • Cell Biology
  • Cytokine Signaling

Background:

  • Interleukin-6 (IL-6) is a cytokine with diverse functions, produced by various cells like monocytes, fibroblasts, and endothelial cells.
  • IL-6 induction is triggered by multiple signals, including lipopolysaccharide (LPS) and Interleukin-1 (IL-1), with cell-type specific responses observed.
  • Previously, IL-1 was not recognized as a potent inducer of IL-6 in monocytes.

Purpose of the Study:

  • To investigate the effect of IL-1 beta on IL-6 production in peripheral blood monocytes.
  • To characterize the nature and molecular properties of IL-6 produced by IL-1-stimulated monocytes.
  • To confirm that IL-1 beta, not contaminants, is responsible for IL-6 induction in monocytes.

Main Methods:

  • Stimulation of human peripheral blood monocytes with purified recombinant IL-1 beta.
  • Measurement of IL-6 activity in cell supernatants using antibody neutralization.
  • Analysis of IL-6 molecular mass via SDS-PAGE and immunoprecipitation.
  • Control experiments using anti-IL-1 beta antibodies to confirm specificity.

Main Results:

  • IL-1 beta was found to be a potent inducer of IL-6 in peripheral blood monocytes.
  • High levels of IL-6 activity were detected in supernatants of IL-1-stimulated monocytes.
  • IL-6 produced by monocytes exhibited size heterogeneity (19-26 Kd), similar to IL-6 from other cell types.
  • Monocyte IL-6 production induced by IL-1 beta was specifically neutralized by anti-IL-1 beta antibodies.

Conclusions:

  • IL-1 beta is a potent inducer of IL-6 in human peripheral blood monocytes.
  • This cytokine-cytokine interaction expands the known signaling pathways for both IL-1 and IL-6.
  • Understanding this interaction is crucial for defining the biological activities and interplay of these cytokines.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...